Yangqing Huang
About
In The Last Decade
Yangqing Huang
19 papers receiving 275 citations
Peers
Comparison fields: 5 of 47
- Epidemiology 128
- Oncology 112
- Hepatology 93
- Surgery 75
- Pulmonary and Respiratory Medicine 65
Countries citing papers authored by Yangqing Huang
This map shows the geographic impact of Yangqing Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangqing Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangqing Huang more than expected).
Fields of papers citing papers by Yangqing Huang
This network shows the impact of papers produced by Yangqing Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangqing Huang. The network helps show where Yangqing Huang may publish in the future.
Co-authorship network of co-authors of Yangqing Huang
This figure shows the co-authorship network connecting the top 25 collaborators of Yangqing Huang. A scholar is included among the top collaborators of Yangqing Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangqing Huang. Yangqing Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 9 | |
| 5 | 4 | |
| 6 | ATOH8 overexpression inhibits the tumor progression and monocyte chemotaxis in hepatocellular carcinoma. | 5 |
| 7 | 6 | |
| 8 | 5 | |
| 9 | 20 | |
| 10 | 7 | |
| 11 | 8 | |
| 12 | Metabolic syndrome relates to high risk in hepatocellular carcinoma: a meta-analysis. | 8 |
| 13 | 30 | |
| 14 | 8 | |
| 15 | 40 | |
| 16 | 2 | |
| 17 | 8 | |
| 18 | 57 | |
| 19 | 1 | |
| 20 | Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases. | 64 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.